Prognostic value of microsatellite instability in sporadic locally advanced rectal cancer following neoadjuvant radiotherapy

Histopathology

Volumn 62, Issue 5, 2013, Pages 723-730

  Du, Changzheng ^a   Zhao, Jun ^a   Xue, Weicheng ^a   Dou, Fangyuan ^a   Gu, Jin ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Microsatellite instability; Neoadjuvant radiotherapy; Prognosis; Rectal cancer; Tumour response

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; NUCLEOTIDE;

ADJUVANT THERAPY; ADULT; ADVANCED CANCER; AGE DISTRIBUTION; AGED; ARTICLE; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOCALLY ADVANCED RECTAL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECTUM CANCER; RETROSPECTIVE STUDY; SEX DIFFERENCE; TUMOR BIOPSY;

ADENOCARCINOMA; ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS;

EID: 84875616984     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12069     Document Type: Article

References (29)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics 2012. CA Cancer J. Clin. 2012; 62; 10-29.
2. Beart RW Jr. Multidisciplinary management of patients with advanced rectal cancer. Clin. Cancer Res. 2007; 13; 6890-6893.
3. Kapiteijn E, Kranenbarg EK, Steup WH et al. Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer. Prospective randomised trial with standard operative and histopathological techniques. Dutch ColoRectal Cancer Group. Eur. J. Surg. 1999; 165; 410-420.
4. Guillem JG, Chessin DB, Cohen AM et al. Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. Ann. Surg. 2005; 241; 829-836.
5. Onaitis MW, Noone RB, Hartwig M et al. Neoadjuvant chemoradiation for rectal cancer: analysis of clinical outcomes from a 13-year institutional experience. Ann. Surg. 2001; 233; 778-785.
6. Ryan R, Gibbons D, Hyland JM et al. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology 2005; 47; 141-146.
7. Davis TW, Wilson-Van PC, Meyers M et al. Defective expression of the DNA mismatch repair protein, MLH1, alters G2-M cell cycle checkpoint arrest following ionizing radiation. Cancer Res. 1998; 58; 767-778.
8. Lawes DA, SenGupta S, Boulos PB. The clinical importance and prognostic implications of microsatellite instability in sporadic cancer. Eur. J. Surg. Oncol. 2003; 29; 201-212.
9. Martin LM, Marples B, Coffey M et al. DNA mismatch repair and the DNA damage response to ionizing radiation: making sense of apparently conflicting data. Cancer Treat. Rev. 2010; 36; 518-527.
10. Franchitto A, Pichierri P, Piergentili R, Crescenzi M, Bignami M, Palitti F. The mammalian mismatch repair protein MSH2 is required for correct MRE11 and RAD51 relocalization and for efficient cell cycle arrest induced by ionizing radiation in G2 phase. Oncogene 2003; 22; 2110-2120.
11. Du CZ, Li J, Cai Y, Sun YS, Xue WC, Gu J. Effect of multidisciplinary team treatment on outcomes of patients with gastrointestinal malignancy. World J. Gastroenterol. 2011; 17; 2013-2018.
12. Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery - the clue to pelvic recurrence? Br. J. Surg. 1982; 69; 613-616.
13. Doyle VJ, Bateman AC. Colorectal cancer staging using TNM 7: is it time to use this new staging system? J. Clin. Pathol. 2012; 65; 372-374.
14. Soreide K, Slewa A, Stokkeland PJ et al. Microsatellite instability and DNA ploidy in colorectal cancer: potential implications for patients undergoing systematic surveillance after resection. Cancer 2009; 115; 271-282.
15. Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology 2010; 138; 2073-2087.
16. Buhard O, Cattaneo F, Wong YF et al. Multipopulation analysis of polymorphisms in five mononucleotide repeats used to determine the microsatellite instability status of human tumors. J. Clin. Oncol. 2006; 24; 241-251.
17. Meng WJ, Sun XF, Tian C et al. Microsatellite instability did not predict individual survival in sporadic stage II and III rectal cancer patients. Oncology 2007; 72; 82-88.
18. Popat S, Hubner R, Houlston RS. Systematic review of microsatellite instability and colorectal cancer prognosis. J. Clin. Oncol. 2005; 23; 609-618.
19. Kim GP, Colangelo LH, Wieand HS et al. Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative Study. J. Clin. Oncol. 2007; 25; 767-772.
20. Des Guetz G, Schischmanoff O, Nicolas P, Perret GY, Morere JF, Uzzan B. Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis. Eur. J. Cancer 2009; 45; 1890-1896.
21. Jover R, Zapater P, Castells A et al. The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status. Eur. J. Cancer 2009; 45; 365-373.
22. Li M, Li JY, Zhao AL, Gu J. Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas. Oncology 2007; 73; 52-57.
23. Hong SP, Min BS, Kim TI et al. The differential impact of microsatellite instability as a marker of prognosis and tumour response between colon cancer and rectal cancer. Eur. J. Cancer 2012; 48; 1235-1243.
24. Charara M, Edmonston TB, Burkholder S et al. Microsatellite status and cell cycle associated markers in rectal cancer patients undergoing a combined regimen of 5-FU and CPT-11 chemotherapy and radiotherapy. Anticancer Res. 2004; 24; 3161-3167.
25. Smith FM, Reynolds JV, Miller N et al. Pathological and molecular predictors of the response of rectal cancer to neoadjuvant radiochemotherapy. Eur. J. Surg. Oncol. 2006; 32; 55-64.
26. Zauber NP, Marotta SP, Berman E et al. Molecular genetic changes associated with colorectal carcinogenesis are not prognostic for tumor regression following preoperative chemoradiation of rectal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 2009; 74; 472-476.
27. Mohiuddin M, Marks J, Marks G. Management of rectal cancer: short- vs. long-course preoperative radiation. Int. J. Radiat. Oncol. Biol. Phys. 2008; 72; 636-643.
28. Vilar E, Gruber SB. Microsatellite instability in colorectal cancer-the stable evidence. Nat. Rev. Clin. Oncol. 2010; 7; 153-162.
29. Sinicrope FA. DNA mismatch repair and adjuvant chemotherapy in sporadic colon cancer. Nat. Rev. Clin. Oncol. 2010; 7; 174-177.